- Weissler JC: Idiopathic pulmonary fibrosis cellular and molecular pathogenesis. Am J Med Sci. 1989;297:91-104.
- Snider GL, Hayes JA, Korthy AL: Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. Am Rev Respir Dis. 1978; 117:1099-1108.
- Coker RK, Laurent GJ: Pulmonary fibrosis: cytokines in the balance; Eur. Respir J. 1998;11:1218-1221.
- Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UT, Liotta LA, Falanga V, Kehrl JH: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Nad Mad Sci U S A. 1986;83:4167-4171.
- Raghow R, Postlethwaite AB, Keski-Oja J, Moses HL, Rang AH: Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Chin Invest 1987;79;1285-1288.
- Raghow R, Lurie S, Seyer JM, Rang AH: Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Chin Invest 1985;76:1733-1739.
- Gurujeyalakshmi G, Hollinger MA, Giri SN: Regulation of transforming growth factor-betal mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis. Am J Respir Cell Mol. Biol. 1998;18:334-342.
- Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE, Ryan ST, Giri SN: Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax. 1999;54:805-812.
- Zia S, Hyde DM, Giri SN: Development of a bleomycin hamster model of subchronic lung fibrosis. Pathology. 1992:24:155-163.
- Wang Q, Giri SN, Hyde DM, Li C: Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol. 1991;42: 1115-1122.
- Iyer SN, Margolin SB, Hyde DM, Giri S N: Lung fibrosis is ameliorated by pirfenidone in diet after the second dose in a three-dose bleomycin hamster model Exp Lung Res. 1998;24:119-132.
- Zheng H, Wang J, Koteliansky VE, Gotwals PJ, Hauerjensen M: Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice. Gastroenterology. 2000:119:1286-1296.
- Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
- Woessner JFJ: The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961;93:440-447.
- Giri SN, Misra HP, Chandler DB, Chen Z: Increases in lung prolyl. hydroxylase and Superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters. Exp Mol Pathol. 1983;39:317-326.
- Karlinski JB, Goldstein CH: Fibritic lung diseases: a perspective. J Lab Chin Med. 1980;96:939-942.
- Gross TJ, Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517-525.
- Shahib FS, Andoh TF, Tanner AM, Noble NA, Border WA, Frenceschini BWM: Role of transforming growth factor-ß in experimental chronic cyclosporin nephropathy. Kidney Int. 1996;49:1141-1151.
- Iyer SN. Gurujeyalakshmi G, Giri SN: Effects of pirfenidone on transforming growth factor-ß gene expression at the transcriptiona level in bleomycin hamster model of lung fibrosis. J. Pharmacol Exp Ther. 1999;291;367-373.
- Yamamoto T, Noble NA, Cohn AH, Nast CD, Hisida A, Gold LI, Border WA: Expression of transforming growth factor-ß isofbrms in human glomerular diseases. Kidney int. 1996;49:461-469.
- Broeckelmann TJ, Limper AH, Colby TB, McDonald JA: Transforming growth factor-ß is present at site of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991;88:6642-6646.
- Khalil N, O'Conner RN, Unrut MW, Warren PW, Flanders KC, Kemp A, Berenzay OH, Green AH: Increased production and immunochemical localization of transforming growth factor-ß in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991;5:155-162.
- Bruijn IA, Roos A, deGues B, deHeer E: Transforming growth factor-ß and the glomerular extracellular matrix in renal pathology. J Lab Chin Med. 1994;123:34-47.
- Edward DR, Murphy G, Reynohd JJ, Whiteman SC, Docherty JP, Angel P, Heath JK: TGF-ß modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987;6:1899-1904.
- Sporn MB, Roberts AB, Wakefield LM, Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth facotr-ß J Cell Biol. 1987;105:1039-1045.
- Giri SN, Hyde DM, Hollinger MA: Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax. 1993;48:959-966.
- Giri SN, Hyde DM, Braun, RK, Gaarde W, Harper JR, Pierschbacher MD: Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem PharmacoL 1997;54:1205-1216.
- Sugigura Y, Kikuchi T: Formation of Superoxide and hydroxy radicals in iron (n)-bleomycin-oxygen system: electron spin resonance detection by spin trapping. J Antibiot (Tokyo).1978;31:1310-1312
- MacDonald GA, Bridle KR, Ward PJ, Walker NI, Houglum K, George DK, Smith JL, Powell LW, Crawford DH, Ramm GA: Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol. 2001;16:599-606.
- Kawaguchi Y, Kitani A, Hara M, Harigai M, Hirose T, Suzuki K, Kawakami M, Hidaka Ishizuka T, Kawagoe M: Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis. J Rheumatol. 1992;19:1195-1201.
- Miller RL, Udenfriend S: Hydroxylation of proline residues in collagen nascent chains. Arch Biochem Biophys. 1970;139:104-113.
- Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Nad Acad Sci U S A. 1993;90:770-774.
- Clark DA, Goker R: Transforming growth factor-beta (TGF-beta). Int J Biochem Cell Biol. 1998;30:293-298.
EFFECTS OF DELAYED TREATMENT WITH TRANSFORMING GROWTH FACTOR-β SOLUBLE RECEPTOR IN A THREE-DOSE BLEOMYCIN MODEL OF LUNG FIBROSIS IN HAMSTERS
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.